Protagonist Therapeutics
(NASDAQ) PTGX
Protagonist Therapeutics Financials at a Glance
Market Cap
$7.89B
Revenue (TTM)
$74.06M
Net Income (TTM)
-$114.71M
EPS (TTM)
-$1.80
P/E Ratio
-67.98
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$121.83
Volume
70,231
Open
$120.55
Price
$121.83
Volume
70,231
Open
$120.55
Previous Close
$121.83
Daily Range
$119.18 - $123.34
52-Week Range
$49.38 - $126.25
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$121.83
Volume
70,231
Open
$120.55
Previous Close
$121.83
Daily Range
$119.18 - $123.34
52-Week Range
$49.38 - $126.25
Estimated Earnings Date
Aug 5, 2026
PTGX News
PTGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protagonist Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
131
CEO
Dinesh V. Patel, PhD
Website
www.protagonist-inc.comHeadquarters
Newark, CA 94560-1160, US
PTGX Financials
Key Financial Metrics (TTM)
Gross Margin
99.45%
Operating Margin
-192.36%
Net Income Margin
-154.88%
Return on Equity
-17.76%
Return on Capital
-25.30%
Return on Assets
-16.45%
Earnings Yield
-1.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.89B
Shares Outstanding
64.31M
Volume
70.23K
Avg. Volume
677.48K
Financials (TTM)
Gross Profit
$73.66M
Operating Income
-$142.47M
EBITDA
-$113.93M
Operating Cash Flow
-$116.64M
Capital Expenditure
$330.00K
Free Cash Flow
-$116.31M
Cash & ST Invst.
$547.79M
Total Debt
$9.78M
Protagonist Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$56.37M
+99.0%
Gross Profit
$55.96M
+97.6%
Gross Margin
99.28%
N/A
Market Cap
$7.89B
N/A
Market Cap/Employee
$63.60M
N/A
Employees
124
N/A
Net Income
$3.78M
+132.5%
EBITDA
$2.69M
+123.5%
Quarterly Fundamentals
Total Cash
$547.79M
-4.6%
Total Debt
$9.78M
-13.9%
Accounts Receivable
$57.12M
+110.9%
Inventory
$0.00
N/A
Long Term Debt
$7.44M
-24.1%
Short Term Debt
$2.34M
+49.2%
Return on Assets
-16.45%
N/A
Return on Invested Capital
-21.49%
N/A
Free Cash Flow
-$49.16M
-139.4%
Operating Cash Flow
-$48.94M
-139.0%